Category of Clinical Inducer | Interacting Drug | Cmax-t | Cmax-u | AUC | Victim Drug | Observed AUC Change | References |
---|---|---|---|---|---|---|---|
μM | μM | H ⋅ μM | % | ||||
Strong, ≥80% decrease in AUC | Rifampicina | 15 | 3.6 | 34 | Midazolam | 98 | Backman et al., 1998; Kanebratt and Anderson, 2008 |
Rifampicina | 11 | 2.7 | 34 | Midazolam | 95 | Eap et al., 2004 | |
Rifampicina | 10 | 2.5 | 34 | Midazolam | 97 | Fahmi et al., 2012; Backman et al., 1996a | |
Rifampicina | 6.5 | 1.6 | 34 | Midazolam | 86 | Adams et al., 2005 | |
Phenytoina | 29 | 7.3 | 468 | Midazolam | 94 | Backman et al., 1996b; Kanebratt and Anderson, 2008 | |
Carbamazepinea | 21 | 5.3 | 1248 | Midazolam | 94 | Backman et al., 1996b; Kanebratt and Anderson, 2008 | |
Carbamazepine | 25 | 6.1 | 1248 | Alprazolam | 58 | Furukori et al.,1998 | |
Moderate, 50–80% decrease in AUC | Phenobarbital | 56 | 28 | 1497 | Nifedipine | 61 | Schellens et al., 1989, Kanebratt and Anderson, 2008 |
Troglitazone | 3.1 | 0.031 | 24 | Simvastatin | 38 | Fahmi et al., 2012; Prueksaritanont et al., 2001; Kanebratt and Anderson, 2008 | |
Troglitazonea | 6.3 | 0.063 | 50 | Midazolam | 67 | Fahmi et al., 2012 | |
Weak, 20–50% decrease in AUC | Terbinafinea | 2.4 | 0.024 | 16 | Midazolam | 25 | Ahonen, et al., 1995 |
Pleconarila | 3.0 | 0.030 | 42 | Midazolam | 35 | Ma, et al., 2006; Fahmi and Ripp, 2010 | |
Pioglitazone | 4.5 | 0.045 | 44 | Simvastatin | −1 | Prueksaritanont et al., 2001; Fahmi and Ripp, 2010 | |
Pioglitazonea | 2.8 | 0.028 | 44 | Midazolam | 26 | Fahmi et al., 2012 | |
Sulfinpyrazone | 48 | 0.96 | 287 | R-Warfarin | 22 | O'Reilly, 1982; Kanebratt and Andersson, 2008 | |
Probenecid | 244 | 24 | 2705 | Carbamazepine | 20 | Kim et al., 2005; Selen et al., 1982 | |
Clinical noninducer | Dexamethasone | 0.021 | 0.0054 | 0.29 | Triazolam | 19 | Fahmi et al., 2012; Kanebratt and Andersson, 2008 |
Nifedipinea | 0.40 | 0.020 | 0.87 | Midazolam | 4 | Fahmi et al., 2012; Kanebratt and Andersson, 2008 | |
Rosiglitazone | 1.7 | 0.0033 | 8.2 | Nifedipine | 12 | Fahmi et al., 2012; Harris et al., 1999; Fahmi and Ripp, 2010 | |
Rosiglitazone | 1.4 | 0.0028 | 8.2 | Ethinylestradiol | −1 | Inglis A et al., 2001; Fahmi and Ripp, 2010 | |
Omeprazole | 0.74 | 0.037 | 1.1 | Nifedipine | −25 | Soons, et al., 1992; Kanebratt and Andersson, 2008 | |
Clotrimazolea | 0.0074 | 0.0001 | NA | Midazolam | 9.7 | Shord et al., 2010 | |
Flumazenil | 0.0010 | 0.0005 | 0.050 | Midazolam | −2 | Fahmi et al., 2012 | |
Quinidine | 3.3 | 0.41 | 42 | NA | 0 | Mihaly et al.,1987; Leizorovicz et al., 1984 |
NA, clinical induction interaction data not available.
↵a Interacting drugs used for preparation of calibration curves.